$1.60
-0.01-0.62%
Benzinga
Benzinga
Benzinga
목요일, 10월 15
Benzinga
© 2026 Benzinga | All Rights Reserved
Lexicon Pharmaceuticals (LXRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.05 | $-0.04 | $-0.07 | $-0.07 |
| Actual | $-0.07 | $0.00 | $-0.04 | $-0.04 |
| Surprise | -40.0% | +100.0% | +42.9% | +42.9% |
| Revenue | ||||
| Estimate | $4.4M | $9.6M | $3.7M | $5.1M |
| Actual | $692000 | $1.1M | $5.5M | $14.2M |
| Surprise | -84.4% | -88.6% | +50.4% | +175.6% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.05 | $-0.04 | $-0.07 | $-0.07 |
| Revenue | ||||
| Consensus | $5.5M | $11.1M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.07 | $-0.05 | -40.0 % |
| Q1 | May 7, 2026 | $0 | $-0.04 | 100.0 % |
| Q4 | Mar 5, 2026 | $-0.04 | $-0.07 | 42.9 % |
| Q3 | Nov 6, 2025 | $-0.04 | $-0.07 | 42.9 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $692.00K | $4.43M | -84.4 % |
| Q1 | May 7, 2026 | $1.09M | $9.57M | -88.6 % |
| Q4 | Mar 5, 2026 | $5.49M | $3.65M | 50.4 % |
| Q3 | Nov 6, 2025 | $14.18M | $5.15M | 175.6 % |